{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/1592720372",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/2038606821"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#1592720372",
  "code": "BD42.0",
  "source": "http://id.who.int/icd/entity/1592720372",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Primary Raynaud disease"
  },
  "definition": {
    "@language": "en",
    "@value": "Raynaud phenomenon unassociated with any concomitant disease, drug or other provoking trauma. Criteria for diagnosis include: bilateral symmetrical episodic attacks without evidence of peripheral vascular disease or tissue injury, normal nail fold capillaroscopy, negative antinuclear antibody and normal erythrocyte sedimentation rate."
  },
  "inclusion": [
    {
      "label": {
        "@language": "en",
        "@value": "Raynaud disease"
      }
    }
  ],
  "relatedEntitiesInMaternalChapter": [
    "http://id.who.int/icd/entity/1380872553"
  ],
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Primary Raynaud disease"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Raynaud disease"
      }
    }
  ]
}